The most common use of these drugs in women is for endometriosis, the symptoms of which may be supressed during pregnancy and while breastfeeding.
The gonadotrophin analogues (‘-relins’) are not active orally and therefore unlikely to be absorbed by the infant. Their properties also suggest they will only be present in milk in negligible amounts. The potential for their use during breastfeeding is very limited.